The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
Open accessAbstract
Caspase-3 is an effector of apoptosis in experimental models of Parkinson's disease (PD). However, its potential role in the human pathology remains to be demonstrated. Using caspase-3 immunohistochemistry on the postmortem human brain, we observed a positive correlation between the degree of neuronal loss in dopaminergic (DA) cell groups affected in the mesencephalon of PD patients and the percentage of caspase-3-positive neurons in these cell groups in control subjects and a significant decrease of caspase-3-positive pigmented neurons in the substantia nigra pars compacta of PD patients compared with controls that also could be observed in an animal model of PD. This suggests that neurons expressing caspase-3 are more sensitive to the pathological process than those that do not express the protein. In addition, using an antibody raised against activated caspase-3, the percentage of active caspase-3-positive neurons among DA neurons was significantly higher in PD patients than in controls. Finally, electron microscopy analysis in the human brain and in vitro data suggest that caspase-3 activation precedes and is not a consequence of apoptotic cell death in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Caspases: the executioners of apoptosis
COHEN, G. M. (1997) · Biochemical Journal · doi:10.1042/bj3260001 · Cited by 4,719
Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., et al. (1995) · Nature · doi:10.1038/376037a0 · Cited by 3,979
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S., & Dixit, V. M. (1995) · Cell · doi:10.1016/0092-8674(95)90541-3 · Cited by 2,367
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice
Kuida, K., Zheng, T. S., Na, S., Kuan, C.-Y., Yang, D., Karasuyama, H., Rakic, P., & Flavell, R. A. (1996) · Nature · doi:10.1038/384368a0 · Cited by 1,882
The substantia nigra of the human brain
Damier, P., Hirsch, E. C., Agid, Y., & Graybiel, A. M. (1999) · Brain · doi:10.1093/brain/122.8.1437 · Cited by 1,756
Self-citationMelanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301
Self-citationApoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
Anglade, P., Vyas, S., Javoy-Agid, F., Herrero, M. T., Michel, P. P., Marquez, J., Prigent, A., Ruberg, M., Hirsch, É. C., & Agid, Y. (1997) · PubMed · Cited by 1,188
Self-citationInhibition of Human Caspases by Peptide-based and Macromolecular Inhibitors
Garcia-Calvo, M., Peterson, E. P., Leiting, B., Ruel, R., Nicholson, D. W., & Thornberry, N. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32608 · Cited by 977
Understanding cell death in parkinson's disease
Jenner, P., & Olanow, C. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440712 · Cited by 685
Hunot, S., Brugg, B., Ricard, D., Michel, P. P., Muriel, M.-P., Ruberg, M., Faucheux, B. A., Agid, Y., & Hirsch, E. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7531 · Cited by 678
Self-citationPettmann, B., & Henderson, C. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81004-1 · Cited by 592
Tatton, N. A., & Kish, S. J. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00545-3 · Cited by 468
Yamada, T., McGeer, P. L., Baimbridge, K. G., & McGeer, E. G. (1990) · Brain Research · doi:10.1016/0006-8993(90)91236-a · Cited by 448
Krajewska, M., Wang, H., Krajewski, S., Zapata, J. M., Shabaik, A. S., Gascoyne, R. D., & Reed, J. C. (1997) · PubMed · Cited by 428
Hunot, S., Dugas, N., Faucheux, B., Hartmann, A., Tardieu, M., Debré, P., Agid, Y., Dugas, B., & Hirsch, E. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-09-03440.1999 · Cited by 408
Self-citationDistinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons
Lotharius, J., Dugan, L. L., & O’Malley, K. L. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01284.1999 · Cited by 403
In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system
Srinivasan, A., Roth, K. A., Sayers, R. O., Shindler, K. S., Wong, A. M., Fritz, L. C., & Tomaselli, K. J. (1998) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400449 · Cited by 368
Self-citationSchulz, J. B., Weller, M., & Klockgether, T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-15-04696.1996 · Cited by 321
Caspases as treatment targets in stroke and neurodegenerative diseases
Schulz, J. B., Weller, M., & Moskowitz, M. A. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199904)45:4<421::aid-ana2>3.0.co;2-q · Cited by 319
Tompkins, M. M., Basgall, E. J., ZAMRINI, E. Y., & Hill, W. D. (1997) · Europe PMC (PubMed Central) · Cited by 314
Du, Y., Bales, K. R., Dodel, R. C., Hamilton-Byrd, E., Horn, J. W., Czilli, D. L., Simmons, L. K., Ni, B., & Paul, S. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11657 · Cited by 279
Armstrong, R. C., Aja, T. J., Hoang, K. D., Gaur, S., Bai, X., Alnemri, E. S., Litwack, G., Karanewsky, D. S., Fritz, L. C., & Tomaselli, K. J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-02-00553.1997 · Cited by 277
A fluorescent double‐labeling method to detect and confirm apoptotic nuclei in parkinson's disease
Tatton, N. A., Maclean‐Fraser, A., Tatton, W. G., Perl, D. P., & Warren, C. O. (1998) · Annals of Neurology · doi:10.1002/ana.410440721 · Cited by 202
Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging.
Anglade, P., Vyas, S., Hirsch, É. C., & Agid, Y. (1997) · PubMed · Cited by 166
Self-citationPrigent, A., Karlsson, J., Agid, Y., & Hirsch, É. C. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00100-5 · Cited by 161
Self-citationDu, Y., Dodel, R. C., Bales, K. R., Jemmerson, R., Hamilton‐Byrd, E., & Paul, S. M. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041382.x · Cited by 161
Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death
Dodel, R. C., Du, Y., Bales, K. R., Ling, Z. D., Carvey, P. M., & Paul, S. M. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00318-0 · Cited by 123
Jeon, B. S., Kholodilov, N. G., Oo, T. F., Kim, S., Tomaselli, K. J., Srinivasan, A. N., Stefanis, L., & Burke, R. E. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730322.x · Cited by 120
Self-citationSynaptic Plasticity in the Caudate Nucleus of Patients with Parkinson's Disease
Anglade, P., Prigent, A., Agid, Y., & Hirsch, É. C. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0018 · Cited by 117
Self-citationProgrammed cell death: Does it play a role in parkinson's disease?
Burke, R. E., & Kholodilov, N. G. (1998) · Annals of Neurology · doi:10.1002/ana.410440719 · Cited by 103
DNA fragmentation in human substantia nigra: Apoptosis or perimortem effect?
Kingsbury, A. E., MARSDEN, C. D., & Foster, O. J. F. (1998) · Movement Disorders · doi:10.1002/mds.870130604 · Cited by 97
Nath, R., Probert, A. W., McGinnis, K., & Wang, K. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71010186.x · Cited by 97
Bcl-2 regulates amplification of caspase activation by cytochrome c
Cosulich, S. C., Savory, P., & Clarke, P. R. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80068-2 · Cited by 90
Michel, P. P., & Agid, Y. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67041633.x · Cited by 87
Self-citationDodel, R. C., Du, Y., Bales, K. R., Ling, Z. D., Carvey, P. M., & Paul, S. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00154-7 · Cited by 78
Sealing one's fate: control of cell death in neurons
Bergeron, L., & Yuan, J. (1998) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(98)80008-1 · Cited by 57
Michel, P. P., Marien, M. R., Ruberg, M., Colpaert, F. C., & Agid, Y. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722074.x · Cited by 52
Self-citationSpooren, W. P. J. M., Gentsch, C., & Wießner, C. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00640-4 · Cited by 38
Cited by
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Blum, D., Torch, S., Lambeng, N., Nissou, M.-F., Benabid, A.-L., Sadoul, R., & Verna, J.-M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00003-x · Cited by 1,246
Degterev, A., Boyce, M., & Yuan, J. (2003) · Oncogene · doi:10.1038/sj.onc.1207107 · Cited by 1,107
Autophagy and apoptosis dysfunction in neurodegenerative disorders
Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S. R., Jangamreddy, J. R., Mehrpour, M., Christoffersson, J., Chaabane, W., Moghadam, A. R., Kashani, H. H., et al. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.10.004 · Cited by 1,039
Mitochondrial dysfunction and oxidative stress in Parkinson's disease
Subramaniam, S. R., & Chesselet, M.-F. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.04.004 · Cited by 913
Metadata
- Authors
- Hartmann, A., Hunot, S., Michel, P. P., Muriel, M.-P., Vyas, S., Faucheux, B. A., Mouatt-Prigent, A., Turmel, H., Srinivasan, A., Ruberg, M., Evan, G. I., Agid, Y., & Hirsch, E. C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-02-25
- Volume
- 97
- Issue
- 6
- Pages
- 2875-2880
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2096298540
- Cited by
- 715
- References
- 40
- FWCI
- 33.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.